GE HealthCare Technologies Inc.
GEHCNasdaqCIK 1932393HealthcareFiscal year ends Dec 31
Reports and events: 78 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2806:25 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000058 |
| 2026-09-2216:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000053 |
| 2026-08-1809:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000050 |
| 2026-07-2906:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000047 |
| 2026-07-2906:27 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001932393-26-000046 |
| 2026-07-2906:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000045 |
| 2026-07-2316:17 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000039 |
| 2026-05-1116:51 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001932393-26-000034 |
| 2026-04-2906:26 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001932393-26-000031 |
| 2026-04-2906:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000030 |
| 2026-03-1907:02 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001932393-26-000021 |
| 2026-03-1709:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000013 |
| 2026-02-2716:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001932393-26-000010 |
| 2026-02-0406:28 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001932393-26-000007 |
| 2026-02-0406:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000006 |
| 2025-12-1517:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319383 |
| 2025-12-0216:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-305400 |
| 2025-10-2906:26 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001932393-25-000053 |
| 2025-10-2906:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000052 |
| 2025-07-3006:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001932393-25-000049 |
| 2025-07-3006:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000048 |
| 2025-07-2416:33 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001932393-25-000044 |
| 2025-06-0916:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000041 |
| 2025-06-0416:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000039 |
| 2025-05-3008:59 ET | 8-K | 5.07 Shareholder vote results | 0001932393-25-000032 |
| 2025-04-3006:26 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001932393-25-000014 |
| 2025-04-3006:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000013 |
| 2025-04-1007:07 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001628280-25-017240 |
| 2025-03-3117:09 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001932393-25-000007 |
| 2025-02-1306:26 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001932393-25-000005 |
| 2025-02-1306:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000004 |
| 2024-12-1216:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-277089 |
| 2024-11-2106:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-24-000054 |
| 2024-11-0816:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-254226 |
| 2024-10-3006:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-24-000051 |
| 2024-10-3006:32 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001932393-24-000050 |
| 2024-10-3006:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000049 |
| 2024-09-1317:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-218963 |
| 2024-08-1516:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-201356 |
| 2024-08-0916:54 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197921 |
| 2024-07-3106:26 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001932393-24-000044 |
| 2024-07-3106:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000043 |
| 2024-05-2316:05 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-024926 |
| 2024-04-3006:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001932393-24-000034 |
| 2024-04-3006:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000033 |
| 2024-04-1517:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001932393-24-000027 |
| 2024-04-0407:06 ET | DEF 14A | Proxy statementPeriod 2024-05-21 | 0001932393-24-000022 |
| 2024-03-1417:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-068035 |
| 2024-02-1617:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-038569 |
| 2024-02-0612:08 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000017 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 06:27 ET. Listed shows no prices and gives no investment advice.